---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-301044"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2022-12-08T23:59:59+00:00"
generated_at: "2026-06-21T07:39:42.317074+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Benitec shareholders reject preferred stock authorization at 2022 annual meeting

## Summary
- Proposal 5 to authorize 5M shares of preferred stock failed; all other proposals passed.
- Directors Jerel Banks and Megan Boston elected with ~98% of votes cast (excluding broker non-votes).
- Shareholders approved increase in authorized common stock, reverse stock split, and advisory say-on-pay.
- Ratification of independent auditor (BDO USA) received 18.7M for, 137k against, 118k abstain.
- Broker non-votes on four proposals totaled 5.2M shares out of 19.0M present at the meeting.

## SEC filing metadata
- accession: 0001193125-22-301044
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2022-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/d352118d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-301044
- JSON: https://secwatch.observer/filing/0001193125-22-301044.json
- Plain text: https://secwatch.observer/filing/0001193125-22-301044.txt

## Key facts
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2022-12-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm. The results were as follows: For Against Abstain 18,739,378 137,128 117,650
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Approval of an Amendment to the Company's Certificate of Incorporation to Effect a Reverse Stock Split of the Company's Common Stock at the 2022-12-07 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 6 – Approval of an Amendment to the Company’s Certificate of Incorporation to Effect a Reverse Stock Split of the Company’s Common Stock. The results were as follows: For Against Abstain 17,463,834 1,528,782 1,540
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Advisory Vote on Executive Compensation at the 2022-12-07 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 3 – Advisory Vote on Executive Compensation. The results were as follows: For Against Abstain Broker Non-Vote 13,411,245 396,016 14,487 5,172,408
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders rejected Approval of an Amendment to the Company's Certificate of Incorporation to Authorize the Issuance of Up to 5,000,000 Shares of Preferred Stock at the 2022-12-07 meeting.
  - Proposal: charter amendment
  - Outcome: failed
  - Meeting: 2022-12-07
  source text: Proposal 5 – Approval of an Amendment to the Company’s Certificate of Incorporation to Authorize the Issuance of Up to 5,000,000 Shares of Preferred Stock. The results were as follows: For Against Abstain Broker Non-Vote 12,501,121 1,316,881 3,746 5,172,408
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Approval of an Amendment to the Company's Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock at the 2022-12-07 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 4 – Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock. The results were as follows: For Against Abstain 15,970,145 2,906,409 117,602
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Approval of the Adjournment of the Annual Meeting, if Necessary, to Solicit Additional Proxies at the 2022-12-07 meeting.
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 7 – Approval of the Adjournment of the Annual Meeting, if Necessary, to Solicit Additional Proxies. The results were as follows: For Against Abstain 15,968,583 2,905,589 119,984
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm
- Shareholder Votes
  Benitec Biopharma Inc. shareholders approved Election of Directors at the 2022-12-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: Proposal 1 – Election of Directors . The results were as follows: Director Nominee For Withhold Broker Non-Votes Dr. Jerel Banks 13,564,345 257,403 5,172,408 Megan Boston 13,528,333 293,415 5,172,408
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522301044/0001193125-22-301044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.